Popular on Rezul
- 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone - 101
- Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
- Torch Entertainment Presents The Frozen Zoo
- Stratum Nutrition's OVOLUX™ Named 2025 "Collagen Ingredient of the Year" by Beauty Innovation Awards
- Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025
- From November 24th to 27th, Fuqing Invites You to Join Us at BIG 5 to Jointly Build a New Future for Middle Eastern Architecture
- Huntington Learning Center of Russellville Marks 1 Year Anniversary; Extends Reduced Grant-Aligned Rates to All Students in Learning Center Services
- Florida landlord-tenant law for property owners and investors
- Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Cut Costs & Boost Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
Similar on Rezul
- Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year
- KIKO NATION TOKEN (Official Release)
- 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
- From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
- T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
- Record Revenues, Debt-Free Momentum & Shareholder Dividend Ignite Investor Attention Ahead of 2026–2027 Growth Targets: IQSTEL (N A S D A Q: IQST)
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
Rezul News/10717711
SAN FRANCISCO - Rezul -- QView Medical, the only company with FDA-approved artificial intelligence for breast ultrasound cancer detection, today announced a strategic partnership with Eve Wellness, the first company to offer direct-to-consumer breast cancer screening.
"We see Eve Wellness as the next frontier in early detection, where AI, ultrasound, and accessibility meet to give women with dense breast tissue confidence and clarity that mammography alone can't provide," said Bob Wang, CEO and founder of QView Medical.
QView's AI platform integrates with GE's Automated Breast Ultrasound (ABUS) system and is deployed in over 100 locations nationwide, including hospitals in Chicago, Atlanta, Salt Lake City, and Los Angeles. Clinical studies show the technology improves cancer detection, particularly in women with dense breast tissue, which can hide tumors in mammography.
"The important part of screening at Eve Wellness is the AI software that comes with it. The AI technology has gotten progressively better and better. It's been about three years since I have found a breast cancer that it wasn't able to pick up," said Dr. Ian Grady, Medical Director at Eve Wellness, on KRON4 TV
More on Rezul News
Eve Wellness has spent more than three years pioneering a patient-centric model that brings advanced breast cancer screening directly to women. By combining QView's FDA-approved AI with GE's 3D whole-breast ultrasound, Eve captures the entire breast, reducing the risk of missed cancers. This approach, which is then analyzed by one of the region's leading Breast Cancer physicians, offers highly effective detection in a more comfortable and convenient environment.
This model is particularly impactful for:
More on Rezul News
QView Medical and Eve Wellness are delivering a new standard in breast screening, one that is highly effective, accessible, and centered on women's needs.
About QView Medical, Inc.
QView Medical is a Silicon Valley, venture-backed AI company that has developed FDA-approved cancer detection AI algorithms, improving early detection and diagnostic accuracy. More information: www.qviewmedical.com
About Eve Wellness
Founded in San Francisco in 2022, Eve Wellness is the first direct-to-consumer breast screening service. Using advanced 3D ultrasound and AI technology, Eve provides women a fast, comfortable, and affordable way to screen. www.myevewellness.com
"We see Eve Wellness as the next frontier in early detection, where AI, ultrasound, and accessibility meet to give women with dense breast tissue confidence and clarity that mammography alone can't provide," said Bob Wang, CEO and founder of QView Medical.
QView's AI platform integrates with GE's Automated Breast Ultrasound (ABUS) system and is deployed in over 100 locations nationwide, including hospitals in Chicago, Atlanta, Salt Lake City, and Los Angeles. Clinical studies show the technology improves cancer detection, particularly in women with dense breast tissue, which can hide tumors in mammography.
"The important part of screening at Eve Wellness is the AI software that comes with it. The AI technology has gotten progressively better and better. It's been about three years since I have found a breast cancer that it wasn't able to pick up," said Dr. Ian Grady, Medical Director at Eve Wellness, on KRON4 TV
More on Rezul News
- Verb™ Presents Features Vanguard Personalized Indexing: Utilizing Advanced Tax-Loss Harvesting Technology
- Zacuto Group Brokers Sale of 1936 Mateo Street in Downtown Los Angeles
- UK Financial Ltd Announces A Special Board Meeting Today At 4PM: Orders MCAT Lock on CATEX, Adopts ERC-3643 Standard, & Cancels $0.20 MCOIN for $1
- Data Over Drama: Market Trends 2026 to discuss what's next for Florida's real estate market
- 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
Eve Wellness has spent more than three years pioneering a patient-centric model that brings advanced breast cancer screening directly to women. By combining QView's FDA-approved AI with GE's 3D whole-breast ultrasound, Eve captures the entire breast, reducing the risk of missed cancers. This approach, which is then analyzed by one of the region's leading Breast Cancer physicians, offers highly effective detection in a more comfortable and convenient environment.
This model is particularly impactful for:
- Younger women under 40 who may not qualify for traditional mammography.
- Women with dense breast tissue, where mammography is known to be limited.
- Women seeking a non-invasive, more comfortable screening experience without hospital visits or physician referrals.
More on Rezul News
- Maryland's Wizard's Escape Becomes a Top Choice for Large Families & Celebration Groups
- From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
- Laurie McLennan and The McLennan Team Announces Strong Finish to 2025 With Notable Luxury Sales in La Quinta and Palm Desert
- Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
- Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
QView Medical and Eve Wellness are delivering a new standard in breast screening, one that is highly effective, accessible, and centered on women's needs.
About QView Medical, Inc.
QView Medical is a Silicon Valley, venture-backed AI company that has developed FDA-approved cancer detection AI algorithms, improving early detection and diagnostic accuracy. More information: www.qviewmedical.com
About Eve Wellness
Founded in San Francisco in 2022, Eve Wellness is the first direct-to-consumer breast screening service. Using advanced 3D ultrasound and AI technology, Eve provides women a fast, comfortable, and affordable way to screen. www.myevewellness.com
Source: Eve Wellness
Filed Under: Consumer
0 Comments
Latest on Rezul News
- Kaufman Development Breaks Ground on Detroit Micro Data Center, Expanding Its National AI Platform
- Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
- $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
- High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
- Top10Christmas.co.uk Releases the UK Christmas Toy Trends 2025 Report
- Talagat Business Academy Announces Joint Certificate Program With The University of Chicago Booth School of Business
- LocaXion and Asseco CEIT Announce First-to-Market RTLS-Driven Digital Twin Platform for Healthcare, Manufacturing, and Logistics
- Slotozilla Launches New Report on How AI Is Reshaping Careers and Society
- OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
- Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
- Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
- What Unique Luxury Homes on Islamorada Key Have to Offer
- America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
- JiT Home Buyers Increases Coverage Across U.S. States and Major Metro Regions
- Florida Realtor Highlights Market Shifts Impacting Buyers and Sellers in Today's Housing Landsca
- Berkshire Hathaway HomeServices FNR Relocation Division honored by Aires Broker Network
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
- Impact & Influence Magazine and Awepra Announce Strategic Relocation to 500 Capitol Mall
- New Homes in Missouri: Ashlar Homes Sets the Standard for Quality, Affordability, and Community
- BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
